Propanc Biopharma Says Preclinical PRP Data In Pancreatic Cancer Models Showed Greater Than 90% Mean Tumor Growth Inhibition, More Than 2.5-Fold Median Survival Extension

뉴스 본문을 불러오고 있어요.

Propanc Biopharma Says Preclinical PRP Data In Pancreatic Cancer Models Showed Greater Than 90% Mean Tumor Growth Inhibition, More Than 2.5-Fold Median Survival Extension | 웨이프 WAPE

Propanc Biopharma Says Preclinical PRP Data In Pancreatic Cancer Models Showed Greater Than 90% Mean Tumor Growth Inhibition, More Than 2.5-Fold Median Survival Extension

기사 요약

관련 종목

댓글 —